Everything you need to know as a first-time student.
Information and support for postgraduate study.
Courses, supervisors and your life as a researcher.
Step-by-step application guides for our courses.
Get financial support for your studies. Find a scholarship that's right for you.
Options like part-time, external and online study can help you tailor how you learn.
Boost your career or extend your skills with a short course or unit.
Our free online courses are open to everyone.
Discover our campuses, courses and entry requirements.
Our internationally recognised research is supported by state-of-the-art research infrastructure.
Considering research with us? Here's what to expect.
PhDs, research masters and professional doctorates.
Apply for scholarships for research study, or competitive grants as a professional researcher.
Our researchers work in supportive and established networks.
We value and promote integrity and ethical responsibility in all research we conduct.
Our strengths and areas of focus in research.
Browse our experts or find a supervisor.
We collaborate with industry partners to research solutions for real-world problems, and to give our students hands-on experience in the workplace.
Work with our students and graduates, sponsor scholarships, prizes or events, or become an industry partner.
We offer commercial research and consultancy services, research commercialisation, and workplace training and development.
We offer short courses to help you advance your career and expand your skills.
We're working with a range of industry partners and collaborators.
Boeing Australia have collaborated on projects with us and provided sponsorship, and their staff have taught in our avionics program.
We are a highly successful and globally positioned Australian university with an applied emphasis in courses and research.
Make a real impact by giving to QUT and supporting our students, researchers and community.
Our history, key statistics, sustainability initiatives and programs and Indigenous acknowledgement.
Meet our staff and executive team.
Our awards, accreditation details, research rankings and scholarly achievements.
Our plans for expanding our university's achievements in learning, teaching and research.
Policies, procedures and annual reports.
What's on at QUT.
Want to work with us? See available jobs.
Our campuses and facilities, including maps, research locations and public venues.
Email: firstname.lastname@example.org Phone: +61 7 3138 2000 Mon-Fri, 8.30am-5pm.
Our graduates run successful businesses, conduct ground-breaking research and make significant contributions to their communities.
We celebrate our alumni with annual awards for graduates and students.
Get involved with QUT by engaging with and supporting our current students.
Once you've graduated, we encourage you to keep in touch with the QUT community and your fellow alumni.
Email: email@example.com Phone: +61 7 3138 4778 Mon-Fri, 8.30am-5pm
Award-winning singer-songwriter and ARIA-nominated artist Kate Miller-Heidke is the 2016 QUT Alumnus of the Year.
Step-by-step guide to applying as an international student.
We offer scholarships for international students to help with study and living costs.
You may be able to meet with a QUT staff member or official representative in your city.
Find out more about living and studying in Brisbane.
While you're studying here, you can access a range of support services to help you adjust to life in Brisbane.
Come to QUT for one or two semesters.
Freecall: 1800 181 848 (within Australia)
Phone: +61 3 9627 4853 (outside Australia)
Subscribe for email updates
Meet the new face of environmental monitoring – a combination of unmanned aerial vehicles (UAV) and a highly specialised camera that was once so big and expensive only satellites and airplanes could carry them.
Email: firstname.lastname@example.org Phone: +61 7 3138 2361
You are here:
Scientists at Queensland University of Technology are one step closer to developing a world-first vaccine to protect women against contracting the most common sexually-transmitted disease, Chlamydia.
A major international vaccine company has awarded QUT a funding boost of more than $300,000 to continue its research into Chlamydia and work towards developing a vaccine specifically targeting adolescent women.
Professor Peter Timms, from QUT's Institute of Health and Biomedical Innovation (IHBI), said a team of researchers had already identified certain proteins that were able to protect against Chlamydia infection.
"We've been testing these proteins as part of animal trials...and we think we've got the answer. It is possible that within three to five years we'll be finished the animal trials and be looking at clinical trials in humans."
Professor Timms said the funding would allow QUT to evaluate the effectiveness of Chlamydia prevention methods developed at the university, as well as compare and test possible other prevention methods being developed.
He said once a vaccine had been developed it could be administered via a patch, similar to ones used by smokers for nicotine.
"Patches are a good way to deliver proteins to a part of the body's immune system and they are also easy and user-friendly."
He said with rates of Chlamydia infection in some Australian communities as high as 12 per cent of the female population, there was a "real need" to develop a vaccine.
"Chlamydia is the most common infectious disease in the world and results in infertility in women and long-term chronic pelvic pain," he said.
"There are antibiotics to treat Chlamydia, but there's no vaccine to prevent it. In many cases women don't know they are infected because there are not really any physical signs or symptoms, so by and large they don't get treatment."
Professor Timms said the fact that a large vaccine company had selected QUT to help develop Chlamydia vaccines points to the value of the work being done at the university.
"Despite this current injection of funds, further work and funding is still needed to take this current research through to a vaccine product," he said.
QUT researchers working on the project are part of IHBI's Cells and Tissue Domain and include Professors Peter Timms, Ken Beagley, Associate Professor Louise Hafner, Celia Berry and Chris Barker.
Media contact - Sandra Hutchinson, QUT media officer, 07 3138 2130 or email@example.com* A high resolution photo of Professor Timms is available for media use**
QUT researcher Professor Peter Timms is working to develop a vaccine for Chlamydia.